PL3274710T3 - Ulepszone testy do oznaczania potencjału ludzkich komórek nabłonka barwnikowego siatkówki (rpe) i komórek progenitorowych fotoreceptorów - Google Patents
Ulepszone testy do oznaczania potencjału ludzkich komórek nabłonka barwnikowego siatkówki (rpe) i komórek progenitorowych fotoreceptorówInfo
- Publication number
- PL3274710T3 PL3274710T3 PL16716342T PL16716342T PL3274710T3 PL 3274710 T3 PL3274710 T3 PL 3274710T3 PL 16716342 T PL16716342 T PL 16716342T PL 16716342 T PL16716342 T PL 16716342T PL 3274710 T3 PL3274710 T3 PL 3274710T3
- Authority
- PL
- Poland
- Prior art keywords
- cells
- epithinal
- rpe
- potential
- determination
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 title 1
- 108091008695 photoreceptors Proteins 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562136660P | 2015-03-23 | 2015-03-23 | |
| PCT/US2016/023839 WO2016154357A1 (en) | 2015-03-23 | 2016-03-23 | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
| EP16716342.7A EP3274710B1 (en) | 2015-03-23 | 2016-03-23 | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3274710T3 true PL3274710T3 (pl) | 2021-12-27 |
Family
ID=55752717
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21167900.6T PL3869195T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowych |
| PL16716342T PL3274710T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy do oznaczania potencjału ludzkich komórek nabłonka barwnikowego siatkówki (rpe) i komórek progenitorowych fotoreceptorów |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21167900.6T PL3869195T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowych |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11422125B2 (pl) |
| EP (3) | EP3274710B1 (pl) |
| JP (4) | JP6902474B2 (pl) |
| KR (2) | KR102577776B1 (pl) |
| CN (3) | CN107889507B (pl) |
| AU (3) | AU2016235176B2 (pl) |
| CA (2) | CA2980580C (pl) |
| DK (1) | DK3274710T3 (pl) |
| ES (2) | ES2877400T3 (pl) |
| HU (1) | HUE054946T2 (pl) |
| IL (3) | IL303401A (pl) |
| MX (2) | MX395233B (pl) |
| PL (2) | PL3869195T3 (pl) |
| PT (2) | PT3869195T (pl) |
| SG (3) | SG10201912315UA (pl) |
| WO (1) | WO2016154357A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6184865B2 (ja) | 2010-07-23 | 2017-08-23 | アステラス インスティテュート フォー リジェネレイティブ メディシン | 細胞の稀少なサブ集団を検出するための方法及び細胞の高度に精製された組成物 |
| PL3869195T3 (pl) | 2015-03-23 | 2024-07-22 | Astellas Institute For Regenerative Medicine | Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowych |
| IL299326A (en) | 2015-08-18 | 2023-02-01 | Astellas Inst For Regenerative Medicine | Clinical formulations |
| WO2021086911A1 (en) | 2019-10-30 | 2021-05-06 | Astellas Institute For Regenerative Medicine | Methods for producing retinal pigment epithelium cells |
| KR102452657B1 (ko) * | 2020-09-09 | 2022-10-11 | 조선대학교 산학협력단 | Noxa 단백질에서 유래한 펩타이드를 포함하는 세포외 소포 생산 촉진용 조성물 및 이를 이용한 세포외 소포의 생산 방법 |
| DE102022103893A1 (de) * | 2022-02-18 | 2023-08-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Membranvesikel, die einen spektroskopisch nachweisbaren Indikator beinhalten, und deren Verwendung in einem Verfahren zum Nachweis der Phagozytose-Funktion bei biologischen Zellen |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432711B1 (en) | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
| US20040199935A1 (en) | 1999-06-30 | 2004-10-07 | Chapman Karen B. | Cytoplasmic transfer to de-differentiate recipient cells |
| US20110171185A1 (en) | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| AU782286B2 (en) | 1999-06-30 | 2005-07-14 | Advanced Cell Technology, Inc. | Cytoplasmic transfer to de-differentiate recipient cells |
| AU7350800A (en) | 1999-09-07 | 2001-04-10 | Advanced Cell Technology, Inc. | Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| US20040180430A1 (en) | 1999-09-07 | 2004-09-16 | West Michael D. | Methods of restoring telomere length and extending cell lifespan using nuclear transfer |
| US20050255596A1 (en) | 1999-09-07 | 2005-11-17 | West Michael D | Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer |
| EP1227719A4 (en) | 1999-11-02 | 2003-01-15 | Univ Massachusetts | USE OF HAPLOID GENOMES FOR GENETIC DIAGNOSIS, MODIFICATION AND MULTIPLICATION |
| US20030213008A1 (en) | 1999-12-20 | 2003-11-13 | Perry Anthony C.F. | Method to produce cloned embryos and adults from cultured cells |
| IL150065A0 (en) | 1999-12-20 | 2002-12-01 | Univ Massachusetts | Embryonic or stem-like cells produced by cross species nuclear transplantation |
| US20020132346A1 (en) | 2001-03-08 | 2002-09-19 | Jose Cibelli | Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| WO2002073188A1 (en) | 2001-03-13 | 2002-09-19 | Advanced Cell Technology, Inc. | Method for generating replacement cells and/or tissues |
| WO2003018760A2 (en) | 2001-08-24 | 2003-03-06 | Advanced Cell Technology, Inc. | Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |
| US20050025750A1 (en) | 2002-12-27 | 2005-02-03 | Fissore Rafael A. | Sperm-induced cellular activation |
| CA2552288C (en) | 2004-01-02 | 2015-02-24 | Advanced Cell Technology, Inc. | Novel culture systems for ex vivo development |
| US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| US20190282622A1 (en) | 2004-01-23 | 2019-09-19 | Astellas Institute For Regenerative Medicine | Modalities for the treatment of degenerative diseases of the retina |
| JP2007522131A (ja) | 2004-01-23 | 2007-08-09 | アドバンスド セル テクノロジー、インコーポレイテッド | 網膜変性疾患治療のための改良された様式 |
| GB0407836D0 (en) | 2004-04-06 | 2004-05-12 | Univ Cambridge Tech | Fluorescent dyes and complexes |
| US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| EP2479256A1 (en) | 2004-11-04 | 2012-07-25 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells |
| US20060263338A1 (en) | 2005-03-04 | 2006-11-23 | Jacoby Douglas B | Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts |
| US8889122B2 (en) | 2005-05-09 | 2014-11-18 | Mytogen, Inc. | Cellular cardiomyoplasty as supportive therapy in patients with heart disease |
| CA2659945C (en) | 2005-08-03 | 2014-12-16 | Advanced Cell Technology, Inc. | Improved methods of reprogramming animal somatic cells |
| WO2007047894A2 (en) | 2005-10-20 | 2007-04-26 | Advanced Cell Technology, Inc. | Totipotent, nearly totipotent or pluripotent mammalian cells homozygous or hemizygous for one or more histocompatibility antigen genes |
| WO2007130664A2 (en) | 2006-05-03 | 2007-11-15 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| WO2008103462A2 (en) | 2007-02-23 | 2008-08-28 | Advanced Cell Technology, Inc. | Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
| WO2009051671A1 (en) | 2007-10-12 | 2009-04-23 | Advanced Cell Technology, Inc. | Improved methods of producing rpe cells and compositions of rpe cells |
| US20110028780A1 (en) | 2007-12-19 | 2011-02-03 | Robert Lanza | Methods Of Producing Pluripotent Stem Cell-Generated Embryos, And Animals Derived Therefrom |
| IL301479B1 (en) | 2009-11-17 | 2025-12-01 | Astellas Inst For Regenerative Medicine | Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| JP6184865B2 (ja) | 2010-07-23 | 2017-08-23 | アステラス インスティテュート フォー リジェネレイティブ メディシン | 細胞の稀少なサブ集団を検出するための方法及び細胞の高度に精製された組成物 |
| US20120184035A1 (en) | 2011-01-13 | 2012-07-19 | Sadhana Agarwal | Methods and Compositions For Reprogramming Cells |
| HUE044778T2 (hu) | 2011-11-14 | 2019-11-28 | Astellas Inst For Regenerative Medicine | Humán RPE sejt gyógyászati készítmények és alkalmazásaik |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| CN104136034B (zh) | 2011-11-30 | 2018-04-24 | 安斯泰来再生医药协会 | 间充质基质细胞及其相关用途 |
| PL2788472T3 (pl) | 2011-12-06 | 2019-06-28 | Astellas Institute For Regenerative Medicine | Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki |
| US9511152B2 (en) | 2012-04-05 | 2016-12-06 | The Board Of Regents Of The University Of Texas System | Multicolored pH-activatable fluorescence nanoplatform |
| ES2896354T3 (es) | 2012-12-21 | 2022-02-24 | Astellas Inst For Regenerative Medicine | Métodos para la producción de plaquetas a partir de células madre pluripotentes |
| DK2970903T3 (da) | 2013-03-15 | 2024-02-19 | Astellas Inst For Regenerative Medicine | Fotoreceptorer og fotoreceptor-progenitorer fremstillet fra pluripotente stamceller |
| US20160175362A1 (en) | 2014-03-14 | 2016-06-23 | Ocata Therapeutics, Inc. | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| US11241460B2 (en) | 2013-03-15 | 2022-02-08 | Astellas Institute For Regenerative Medicine | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| US20160175361A1 (en) | 2014-03-14 | 2016-06-23 | Advanced Cell Technology, Inc. | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| US20170274019A1 (en) | 2014-09-05 | 2017-09-28 | Astellas Institute For Regenerative Medicine | Retinal ganglion cells and progenitors thereof |
| PL3869195T3 (pl) * | 2015-03-23 | 2024-07-22 | Astellas Institute For Regenerative Medicine | Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowych |
| IL299326A (en) | 2015-08-18 | 2023-02-01 | Astellas Inst For Regenerative Medicine | Clinical formulations |
-
2016
- 2016-03-23 PL PL21167900.6T patent/PL3869195T3/pl unknown
- 2016-03-23 KR KR1020177030540A patent/KR102577776B1/ko active Active
- 2016-03-23 EP EP16716342.7A patent/EP3274710B1/en active Active
- 2016-03-23 HU HUE16716342A patent/HUE054946T2/hu unknown
- 2016-03-23 AU AU2016235176A patent/AU2016235176B2/en active Active
- 2016-03-23 ES ES16716342T patent/ES2877400T3/es active Active
- 2016-03-23 CA CA2980580A patent/CA2980580C/en active Active
- 2016-03-23 CA CA3188112A patent/CA3188112A1/en active Pending
- 2016-03-23 CN CN201680029779.7A patent/CN107889507B/zh active Active
- 2016-03-23 KR KR1020237030529A patent/KR20230132893A/ko active Pending
- 2016-03-23 US US15/560,584 patent/US11422125B2/en active Active
- 2016-03-23 PL PL16716342T patent/PL3274710T3/pl unknown
- 2016-03-23 ES ES21167900T patent/ES2980659T3/es active Active
- 2016-03-23 WO PCT/US2016/023839 patent/WO2016154357A1/en not_active Ceased
- 2016-03-23 SG SG10201912315UA patent/SG10201912315UA/en unknown
- 2016-03-23 SG SG11201707775TA patent/SG11201707775TA/en unknown
- 2016-03-23 EP EP24154934.4A patent/EP4343331A3/en active Pending
- 2016-03-23 IL IL303401A patent/IL303401A/en unknown
- 2016-03-23 CN CN202111336261.7A patent/CN113930476B/zh active Active
- 2016-03-23 JP JP2017550191A patent/JP6902474B2/ja active Active
- 2016-03-23 PT PT211679006T patent/PT3869195T/pt unknown
- 2016-03-23 DK DK16716342.7T patent/DK3274710T3/da active
- 2016-03-23 SG SG10201907918V patent/SG10201907918VA/en unknown
- 2016-03-23 IL IL293110A patent/IL293110B2/en unknown
- 2016-03-23 MX MX2017012259A patent/MX395233B/es unknown
- 2016-03-23 EP EP21167900.6A patent/EP3869195B1/en active Active
- 2016-03-23 CN CN202411118882.1A patent/CN118995872A/zh active Pending
- 2016-03-23 PT PT167163427T patent/PT3274710T/pt unknown
-
2017
- 2017-09-24 IL IL254617A patent/IL254617B/en unknown
- 2017-09-25 MX MX2022010736A patent/MX2022010736A/es unknown
-
2021
- 2021-06-21 JP JP2021102569A patent/JP7386206B2/ja active Active
-
2022
- 2022-08-15 US US17/887,783 patent/US11680941B2/en active Active
- 2022-08-17 AU AU2022218516A patent/AU2022218516B2/en active Active
-
2023
- 2023-05-12 US US18/316,785 patent/US20230408489A1/en active Pending
- 2023-11-13 JP JP2023192860A patent/JP2024037720A/ja active Pending
-
2025
- 2025-08-01 JP JP2025129163A patent/JP2025183199A/ja active Pending
- 2025-09-05 AU AU2025226799A patent/AU2025226799A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016001868A1 (es) | Proteinas de union y sus métodos de uso | |
| HRP20251095T1 (hr) | Neoantigeni i metode njihove uporabe | |
| IL282048A (en) | Oxysterols and methods of use thereof | |
| IL259747A (en) | Antibodies targeting fc receptor-like 5 and methods of use | |
| IL254039A0 (en) | Anti-pvrig antibodies and methods of use | |
| HUE058755T2 (hu) | Anti-tigit antigénkötõ proteinek és felhasználásuk módszerei | |
| PL3353210T3 (pl) | Przeciwciała anty-TIGIT i sposoby stosowania | |
| IL254734B1 (en) | Modified t cells and methods of making and using the same | |
| BR112017004802A2 (pt) | anticorpos anti-cll-1 e imunoconjugados | |
| IL251970B (en) | Anti-cd79b antibodies and methods of use | |
| MX384364B (es) | Anticuerpos anti-pd-l1 y sus usos de diagnóstico. | |
| HUE046756T2 (hu) | Benzoxazepin-oxazolidinon vegyületek és azok alkalmazási módszerei | |
| PT3215532T (pt) | Anticorpos anti-tim3 e métodos de utilização | |
| PT3548033T (pt) | Compostos e respectivos métodos de utilização | |
| MA42243A (fr) | Anticorps de facteur xi et méthodes d'utilisation | |
| CR20170240A (es) | Anticuerpos anti-interleucina-33 y sus usos | |
| IL269334A (en) | Improved t cell compositions and methods | |
| BR112018000129A2 (pt) | oxiesteróis e seus métodos de utilização | |
| PL3250610T3 (pl) | Przeciwciała anty-FcRn i sposoby ich stosowania | |
| EP3119761C0 (en) | ANTI-AMYLOID AGENTS AND METHODS OF USE THEREOF | |
| EP3394065A4 (en) | TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE AND METHOD OF USE THEREOF | |
| BR112017004648A2 (pt) | simuladores mir-29 e os usos deste | |
| EA201691610A8 (ru) | Анти-jagged1 антитела и способы применения | |
| EP3303435A4 (en) | HYDROFLUOROLEFINES AND METHOD OF USE THEREOF | |
| IL254670A0 (en) | Humanized anti-c1s antibodies and methods of use thereof |